SCHEMBL4624849

SCHEMBL4624849

O=C(O)N1CCN(C(=O)C(c2ccc(O)cc2)C2(O)CCCCC2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
OPRM1 P35372 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CHRM3 P20309 3/20 0.37
CHRM2 P08172 2/20 0.37
CHRM1 P11229 2/20 0.37
CHRM4 P08173 1/20 0.37
LMNA P02545 3/20 0.36
ALDH1A1 P00352 4/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HPGD P15428 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27681435 0.88 SLC6A2 (0.43) SLC6A2SLC6A4LMNAALDH1A1KMT2A
SCHEMBL27661851 0.88 SLC6A2 (0.43) SLC6A2OPRM1RAB9A
SCHEMBL27655992 0.88 LMNA (0.39) OPRM1CHRM3CHRM2CHRM1CHRM4
SCHEMBL27675975 0.84 NPSR1 (0.40) OPRM1CHRM3CHRM2CHRM1LMNA
SCHEMBL27681429 0.84 SLC6A2 (0.39) SLC6A2SLC6A4LMNAALDH1A1SMN1; SMN2
SCHEMBL3961302 0.82 KMT2A (0.43) SLC6A2SLC6A4OPRM1SLC6A3LMNA
SCHEMBL27662478 0.82 SLC6A2 (0.49) SLC6A2SLC6A4
SCHEMBL27656144 0.81 DPP7 (0.46) ALDH1A1MAPTPOLBSMN1; SMN2RAB9A
SCHEMBL27656082 0.81 LMNA (0.41) SLC6A2SLC6A4SLC6A3CHRM3CHRM2
SCHEMBL3954346 0.79 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1687288-B1 SUBSTITUTED ARYL CYCLOALKANOL DERIVATIVES AND METHODS OF THEIR USE WYETH CORP (US) 2008-01-16 EP disclosed
CN-1972920-A Arylalkyl piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms WYETH CORP (US) 2007-05-30 CN disclosed
CN-1894226-A Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use WYETH CORP (US) 2007-01-10 CN disclosed